As presented in Table 3, the minimum width of rim fluorescence surrounding tumors is negatively associated with the tumor type, tumor size, liver cirrhosis, neoadjuvant chemotherapy, and KRAS and BRAF mutation (all P > 0.05). Here, KRAS is linked to neoplasm.